Retirement Systems of Alabama Buys 23,906 Shares of HealthEquity, Inc. $HQY

Retirement Systems of Alabama increased its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 12.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 220,184 shares of the company’s stock after purchasing an additional 23,906 shares during the quarter. Retirement Systems of Alabama owned 0.27% of HealthEquity worth $19,477,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Allspring Global Investments Holdings LLC raised its position in HealthEquity by 8.1% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 219,109 shares of the company’s stock valued at $19,582,000 after purchasing an additional 16,418 shares in the last quarter. Ethic Inc. boosted its stake in shares of HealthEquity by 21.9% in the 3rd quarter. Ethic Inc. now owns 4,155 shares of the company’s stock valued at $368,000 after buying an additional 746 shares during the period. Commonwealth Equity Services LLC boosted its stake in shares of HealthEquity by 92.9% in the 3rd quarter. Commonwealth Equity Services LLC now owns 4,357 shares of the company’s stock valued at $385,000 after buying an additional 2,098 shares during the period. Provenance Wealth Advisors LLC acquired a new position in shares of HealthEquity during the third quarter worth about $187,000. Finally, Vise Technologies Inc. grew its position in shares of HealthEquity by 44.3% during the third quarter. Vise Technologies Inc. now owns 4,922 shares of the company’s stock worth $435,000 after buying an additional 1,510 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Down 0.5%

Shares of NASDAQ HQY opened at $103.03 on Thursday. The company has a market capitalization of $8.52 billion, a price-to-earnings ratio of 37.20, a price-to-earnings-growth ratio of 1.63 and a beta of 0.22. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. The business has a 50-day moving average of $95.90 and a two-hundred day moving average of $89.78. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $110.26.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The business had revenue of $350.73 million during the quarter, compared to analysts’ expectations of $349.22 million. The firm’s quarterly revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, analysts forecast that HealthEquity, Inc. will post 3.94 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In related news, Director Adrian Dillon sold 7,632 shares of the company’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the transaction, the director directly owned 62,395 shares of the company’s stock, valued at $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of analysts recently weighed in on HQY shares. Telsey Advisory Group set a $111.00 target price on shares of HealthEquity in a research note on Friday, August 28th. BTIG Research reiterated a “buy” rating and issued a $115.00 price target on shares of HealthEquity in a research note on Friday, August 28th. Barclays boosted their price target on shares of HealthEquity from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Friday, September 18th. BMO Capital Markets boosted their price target on shares of HealthEquity from $105.00 to $125.00 and gave the stock an “outperform” rating in a report on Wednesday, October 21st. Finally, Deutsche Bank increased their price objective on shares of HealthEquity from $135.00 to $142.00 and gave the company a “buy” rating in a research report on Monday, August 31st. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and an average price target of $113.53.

HealthEquity Company Profile

HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.